Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia

Volume: 113, Issue: 2, Pages: 262 - 278
Published: Jun 30, 2021
Abstract
The worldwide prevalence and incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and of NENs, in general, have been increasing recently. While valuing the considerable progress made in the treatment strategies for GEP-NEN in recent years, patients with advanced, metastasized disease still have a poor prognosis, which calls for urgent novel therapies. The immune system plays a dual role: both host-protecting and...
Paper Details
Title
Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia
Published Date
Jun 30, 2021
Volume
113
Issue
2
Pages
262 - 278
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.